Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

2(33%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

17%

Ph not_applicable

33%

Ph phase_1

17%

Ph phase_4

17%

Ph phase_3

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

1(16.7%)

Phase 2Efficacy & side effects

1(16.7%)

Phase 3Large-scale testing

1(16.7%)

Phase 4Post-market surveillance

1(16.7%)

N/ANon-phased studies

2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Detailed Status

Completed4

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (16.7%)

Phase 21 (16.7%)

Phase 31 (16.7%)

Phase 41 (16.7%)

N/A2 (33.3%)

Trials by Status

active_not_recruiting117%

recruiting117%

completed467%

Recent Activity

2 active trials

Showing 5 of 6

active_not_recruitingphase_1

Clinical Trials (6)

Showing 6 of 6 trials

NCT00494728Phase 1

Smoking Cessation for Depressed Smokers

Active Not Recruiting

NCT06410599Phase 2

Pharmacologic Treatment Augmentation in Chronic Depression

Recruiting

NCT02748187Not Applicable

Attachment Style and Reflective Functioning in CBASP

Completed

NCT00057551Phase 4

Research Evaluating the Value of Augmenting Medication With Psychotherapy

Completed

NCT02149381Not Applicable

Psychosocial Group Interventions for Depression

Completed

NCT01464463Phase 3

The Impact of Psychological Interventions on Psychometric and Immunological Measures in Patients With Major Depression

Completed

All 6 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 6